Litcius/Paper detail

“Trojan Horse” Phototheranostics: Fine‐Engineering NIR‐II AIEgen Camouflaged by Cancer Cell Membrane for Homologous‐Targeting Multimodal Imaging‐Guided Phototherapy

Jie Cui, Fei Zhang, Dingyuan Yan, Ting Han, Lei Wang, Dong Wang, Ben Zhong Tang

2023Advanced Materials125 citationsDOI

Abstract

Multimodal phototheranostics on the basis of a single molecule with one-for-all characteristics represents a convenient approach for effective cancer treatment. In this report, a versatile molecule featured by aggregation-induced emission, namely DHTDP, synchronously enabling second near-infrared (NIR-II) fluorescence emission and efficient photothermal conversion is developed by elaborate structural modulation. By camouflaging DHTDP nanoparticles with cancer cell membrane, the resultant biomimetic nanoparticles exhibit significantly both facilitated delivery efficiency and homologous targeting capability, and afford precise imaging guidance and maximize therapeutic outcomes in form of NIR-II fluorescence imaging (FLI)-photoacoustic imaging (PAI)-photothermal imaging (PTI) trimodal imaging-guided photothermal therapy (PTT). This study presents the first example of biomimetic multimodal phototheranostics loaded by homogeneity-targeting cell membrane, thus brings a new insight into the exploration of superior phototheranostics for practical cancer theranostics.

Topics & Concepts

Photothermal therapyMaterials scienceNanotechnologyPhotoacoustic imaging in biomedicineCancer cellFluorescenceFluorescence-lifetime imaging microscopyNanoparticleAggregation-induced emissionPhotothermal effectBiophysicsCancerOpticsMedicineBiologyInternal medicinePhysicsNanoplatforms for cancer theranosticsPhotoacoustic and Ultrasonic ImagingLuminescence and Fluorescent Materials
“Trojan Horse” Phototheranostics: Fine‐Engineering NIR‐II AIEgen Camouflaged by Cancer Cell Membrane for Homologous‐Targeting Multimodal Imaging‐Guided Phototherapy | Litcius